|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/155 | |
| A61K 31/5383 | |||
| A61P 3/10 |
| (11) | Number of the document | 2945618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14702159.6 |
| Date of filing the European patent application | 2014-01-14 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/011394 |
| Date | 2014-01-14 |
| (87) | Number | WO 2014/113357 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 201361753567 P | 2013-01-17 | US |
| (72) |
MJALLI, Adnan M.M., US
CLARK, Bradley Alan, US
POLISETTI, Dharma Rao, US
QUADA, JR., James C., US
VALCARCE LOPEZ, Maria Carmen, US
ANDREWS, Robert Carl, US
DAVIS, Stephen Thomas, US
YOKUM, Thomas Scott, US
|
| (73) |
vTv Therapeutics LLC,
4170 Mendenhall Oaks Parkway, High Point, NC 27265,
US
|
| (54) | COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS |
| COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS |